EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

A decade of clinical course and prognostic determinants in type 1 autoimmune pancreatitis: insights from a 10-year longitudinal multicenter retrospective study

Masaki Miyazawa, Hajime Takatori, Masaki Nishitani, Takuya Komura, Kiichiro Kaji, Masaaki Yano, Kazuya Kitamura, Ryotaro Nakai, Hiroki Matsukawa, Naoki Takemura, Masahiro Yanagi, Kazuki Nagai und 9 weitere

Journal of Gastroenterology · 2026

DOI: 10.1007/s00535-026-02448-8 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology, 2026. Verfasst von Masaki Miyazawa und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan. miyacchi_1985@yahoo.co.jp. Hauptthemen laut MEDLINE: Autoimmune Pancreatitis, Adrenal Cortex Hormones. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kanazawa University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Type 1 autoimmune pancreatitis (AIP) is a unique form of pancreatitis characterized by IgG4-related inflammation and corticosteroid (CS) responsiveness, but long-term outcomes remain unclear. We evaluated 10-year relapse, malignancy, metabolic/nutritional changes, and survival.

Methods

We retrospectively analyzed 83 CS-treated patients with type 1 AIP followed for ≥ 10 years or until death, assessing: relapse and risk factors; standardized incidence ratios (SIRs) and risk factors for malignancies; 10-year changes in HbA1c and serum albumin; CS-related adverse events; and overall survival (OS).

Results

Cumulative relapse rates at 1, 3, 5, 7, and 10 years were 11.0%, 26.9%, 38.3%, 50.0%, and 56.9%. CS discontinuation independently predicted relapse, whereas serum IgG4 normal at diagnosis or normalized after CS was protective. Overall malignancy risk was not increased (SIR 1.00; 95%CI 0.59–1.42), while pancreatic cancer (PC) showed a numerically higher SIR (1.98 overall; 2.96 ≥ 5 years postdiagnosis). In 72 patients with 10-year laboratory follow-up, HbA1c improved at 3 years but tended to worsen at 10 years, and serum albumin declined by 10 years (mean − 0.27 g/dL), exceeding age-related norms. Preexisting diabetes attenuated albumin decline. Ten-year survival was 85.5%, and CS maintenance was associated with better OS.

Conclusions

Type 1 AIP shows progressive relapse and metabolic deterioration over a decade, while CS maintenance and IgG4 normalization confer long-term protection. Although the overall risk of malignancy was not increased, the incidence of PC during late follow-up was slightly higher. These findings highlight the need for continuous monitoring for relapse, PC, and nutritional decline in AIP management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune PancreatitisAdrenal Cortex HormonesHumansRetrospective StudiesFemaleMaleMiddle AgedPrognosisRecurrenceLongitudinal StudiesRisk FactorsAgedImmunoglobulin GSerum AlbuminPancreatic NeoplasmsGlycated HemoglobinAdultSurvival RateFollow-Up StudiesTime Factors

Stichwörter der Autor:innen

Autoimmune pancreatitisCorticosteroid therapyIgG4-related diseaseLong-term prognosisRelapse and malignancy

Substanzen

Immunoglobulin GAdrenal Cortex HormonesSerum AlbuminGlycated Hemoglobin

Autor:innen und Institutionen

  • Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan. miyacchi_1985@yahoo.co.jp.
  • Department of Gastroenterology, Kanazawa University Hospital, Kanazawa, Japan.
  • Department of Gastroenterology, Public Central Hospital of Matto Ishikawa, Hakusan, Japan.
  • Department of Gastroenterology, National Hospital Organization Kanazawa Medical Center, Kanazawa, Japan.
  • Department of Gastroenterology, Japanese Red Cross Kanazawa Hospital, Kanazawa, Japan.
  • Department of Gastroenterology, Toyama Prefectural Central Hospital, Toyama, Japan.

Förderung

  • Kanazawa University

Zitieren

APA

Miyazawa, M., Takatori, H., Nishitani, M., Komura, T., Kaji, K., Yano, M., Kitamura, K., Nakai, R., Matsukawa, H., Takemura, N., Yanagi, M., Nagai, K., Kido, H., Takata, N., Hayashi, T., Seki, A., Nio, K., Yamada, S., Iida, N., …, & Yamashita, T. (2026). A decade of clinical course and prognostic determinants in type 1 autoimmune pancreatitis: insights from a 10-year longitudinal multicenter retrospective study. Journal of Gastroenterology. https://doi.org/10.1007/s00535-026-02448-8

Vancouver

Miyazawa M, Takatori H, Nishitani M, Komura T, Kaji K, Yano M, et al. A decade of clinical course and prognostic determinants in type 1 autoimmune pancreatitis: insights from a 10-year longitudinal multicenter retrospective study. Journal of Gastroenterology. 2026. doi:10.1007/s00535-026-02448-8

BibTeX
@article{Miyazawa2026,
  author = {Miyazawa, Masaki and Takatori, Hajime and Nishitani, Masaki and Komura, Takuya and Kaji, Kiichiro and Yano, Masaaki and Kitamura, Kazuya and Nakai, Ryotaro and Matsukawa, Hiroki and Takemura, Naoki and Yanagi, Masahiro and Nagai, Kazuki and Kido, Hidenori and Takata, Noboru and Hayashi, Tomoyuki and Seki, Akihiro and Nio, Kouki and Yamada, Shinya and Iida, Noriho and Shimakami, Tetsuro and Yamashita, Taro},
  title = {A decade of clinical course and prognostic determinants in type 1 autoimmune pancreatitis: insights from a 10-year longitudinal multicenter retrospective study},
  journal = {Journal of Gastroenterology},
  year = {2026},
  doi = {10.1007/s00535-026-02448-8}
}
Kostenlos starten →